Recombinant Shingles Vaccination and the Risk of Cardiovascular Events

Recombinant shingles vaccination and the risk of cardiovascular events

The recombinant herpes zoster (shingles) vaccine may reduce risks of cardiovascular disease. However, existing studies have compared vaccine recipients with non-recipients and, thus, are susceptible to confounding. To mitigate these biases, we conducted a natural experiment created by the rapid transition from the live attenuated to the recombinant shingles vaccine in the United States. We compared incidences of a composite cardiovascular endpoi…

NHS shingles jab could lower risk of stroke and heart attacks

Shingles is caused by the herpes zoster virus flaring up again in people who previously had chicken pox